Quality control (QC) was an essential part of the COVID-19 vaccine development workflow helping to confirm IVT RNA sample integrity and quickly enable the production of robust final vaccine products. In this video, hear from the Agilent team about working with pharmaceutical companies to successfully produce high-quality COVID-19 vaccines using automated electrophoresis solutions for sample QC.


   

 

     

Access additional resources about sample QC using the Agilent automated electrophoresis portfolio: Sample quality control with automated electrophoresis | Agilent.